Pelthos Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $7,406 | $0 | $0 | $0 |
Gross Profit | 4,022 | |||
EBITDA | -14,215 | -3,230 | -1,833 | -1,818 |
EBIT | -15,357 | |||
Net Income | -16,238 | -3,448 | -1,967 | -1,926 |
Net Change In Cash | 7,406 | 0 | 0 | 0 |
Free Cash Flow | -15,258 | -447 | -632 | -670 |
Cash | 14,253 | 59 | 131 | 513 |
Basic Shares | 640 | 640 | 612 | 596 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,168 | -6,862 | -2,318 | -595 |
Net Income | -7,955 | -7,380 | -2,458 | -595 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,792 | -981 | -1,567 | -1,593 |
Cash | 513 | 96 | 55 | 0 |
Basic Shares | 587 | 576 | 576 | 576 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$5.30 |
2025-06-30 | -$5.38 |
2025-03-31 | -$3.21 |
2024-09-30 | -$2.90 |
